Shanghai, China

Yajun Huang

USPTO Granted Patents = 1 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):

Title: Yajun Huang: Innovator in Monoclonal Antibody Development

Introduction

Yajun Huang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has the potential to impact therapeutic strategies in cancer treatment.

Latest Patents

Yajun Huang holds a patent for an "Anti-human LAG-3 monoclonal antibody and use thereof." This invention discloses an antibody that targets LAG-3, along with a preparation method and its applications. The novel monoclonal antibody exhibits high specificity in binding LAG-3 antigens and demonstrates significant anti-tumor activity.

Career Highlights

Yajun Huang is associated with Jiangsu Huaiyu Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work in the pharmaceutical industry has positioned him as a key player in the field of immunotherapy.

Collaborations

Yajun Huang collaborates with talented professionals, including Ningning Song and Qing Duan, who contribute to his research initiatives. Their combined expertise enhances the innovative potential of their projects.

Conclusion

Yajun Huang's contributions to monoclonal antibody development exemplify the importance of innovation in biotechnology. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…